In Vitro Cell Quality Tests of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology

被引:0
|
作者
Ostrowski, S. R. [1 ]
Bochsen, L. [1 ]
Salado-Jimena, J. A. [1 ]
Ullum, H. [1 ]
Reynaerts, I. [2 ]
Goodrich, R. P. [2 ]
Johansson, P. I. [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Clin Immunol, Sect Transfus Serv, DK-2100 Copenhagen, Denmark
[2] CaridianBCT Biotechnol, Lakewood, CO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:93A / 94A
页数:2
相关论文
共 50 条
  • [1] In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology
    Ostrowski, Sisse R.
    Bochsen, Louise
    Salado-Jimena, Jose A.
    Ullum, Henrik
    Reynaerts, Inge
    Goodrich, Raymond P.
    Johansson, Par I.
    [J]. TRANSFUSION, 2010, 50 (10) : 2210 - 2219
  • [2] Hemostatic Function of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology
    Ostrowski, S. R.
    Bochsen, L.
    Salado-Jimena, J. A.
    Ullum, H.
    Reynaerts, I.
    Goodrich, R. P.
    Johansson, P. I.
    [J]. TRANSFUSION, 2009, 49 : 97A - 98A
  • [3] MIRASOL® PATHOGEN REDUCTION TECHNOLOGY TREATMENT OF ORBISAC BUFFY COAT PLATELETS SUSPENDED IN ADDITIVE SOLUTION
    Maia, S.
    Rio, N.
    Marques, S.
    Rouse, L.
    [J]. VOX SANGUINIS, 2010, 99 : 245 - 246
  • [4] Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System
    Castrillo, Azucena
    Cardoso, Marcia
    Rouse, Lindsay
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2013, 40 (01) : 44 - 48
  • [5] TREATMENT OF ORBISAC DERIVED BUFFY COAT PLATELETS WITH THE MIRASOL® PATHOGEN REDUCTION TECHNOLOGY AND STORAGE IN ADDITIVE SOLUTION
    Reikvam, H.
    Hervig, T.
    Marschner, S.
    Goodrich, R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 284 - 284
  • [6] Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology
    Ostrowski, Sisse R.
    Bochsen, Louise
    Windelov, Nis A.
    Salado-Jimena, Jose A.
    Reynaerts, Inge
    Goodrich, Raymond P.
    Johansson, Par I.
    [J]. TRANSFUSION, 2011, 51 (02) : 344 - 356
  • [7] PATHOGEN REDUCTION TECHNOLOGY WITH MIRASOL® FOR THE TREATMENT OF ORBISAC BUFFY COAT PLATELETS IN THE PRESENCE OF DIFFERENT ADDITIVE SOLUTIONS
    Yanez Izquierdo, M.
    Moya San Pedro, A.
    Blanco Penis, L.
    [J]. VOX SANGUINIS, 2010, 99 : 201 - 201
  • [8] Mirasol® Treatment of Buffy Coat Platelets Suspended in Additive Solution
    de Korte, D.
    Vlaar, R.
    Gouwerok, E.
    Marschner, S.
    Hansen, E.
    Reynaerts, I.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2009, 49 : 85A - 85A
  • [9] The Mirasol® Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution
    Reikvam, Hakon
    Marschner, Susanne
    Apelseth, Torunn Oveland
    Goodrich, Ray
    Hervig, Tor
    [J]. BLOOD TRANSFUSION, 2010, 8 (03) : 186 - 192
  • [10] Analysis of platelets treated with Mirasol® Pathogen Reduction Technology and stored in platelet additive solution (PAS)
    Marschner, S.
    Cardigan, R.
    Cookson, P.
    de Korte, Dirk
    Dumont, Larry J.
    Einarson, M.
    Herschel, L.
    Janetzko, K.
    Vassallo, R.
    Goodrich, R.
    [J]. TRANSFUSION, 2008, 48 (02) : 148A - 148A